Demergers & amalgamations
Every company here filed a step of a scheme of arrangement inside the window: a demerger or amalgamation approved by the board, an exchange observation letter, a court-convened shareholder or creditor meeting, the NCLT's sanction, or the record date that makes it real. The filing on each row shows which stage the scheme has reached.
| Company | Why it’s here — the filing | Reaction 1d / 1w / 1m | Price | Mcap |
|---|---|---|---|---|
| Piramal Finance files NCLT petition seeking sanction of amalgamation scheme | +0.3% +1.6% -0.9% | ₹2,221 | 50,339 Cr | |
| Belrise gets no adverse observations from NSE and BSE for merger scheme | -0.5% +1.3% +5.6% | ₹241 | 21,461 Cr | |
| Ipca Labs board approves merger of Krebs Biochemicals | +5.4% +8.9% +9.6% | ₹2,006 | 50,902 Cr | |
| NCLT meetings approve Apollo Hospitals composite scheme of arrangement | +1.6% +1.9% +4.0% | ₹8,930 | 1.28 L Cr |
A company appears when an NSE/BSE filing inside the last 90 days carries one of these classifier signals (minimum importance: Medium): Nclt Scheme Filed, Demerger Ratio Announced. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move 1 day, 1 week and 1 month after that filing.
MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.